Keyphrases
Chemotherapy
100%
Targeted Therapy
100%
Surgical Castration
100%
Castration-resistant Prostate Cancer
100%
Castration Resistance
100%
Tumor
50%
New Agents
50%
Prostate Cancer
50%
Androgens
50%
U.S. Food
50%
Local Therapy
50%
Novel Agents
50%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
50%
Treatment Paradigms
50%
First-line Therapy
50%
Recurrent Prostate Cancer
50%
Cabazitaxel
50%
Abiraterone
50%
Enzalutamide
50%
Salvage Chemotherapy
50%
Medicine and Dentistry
Prostate Cancer
100%
Targeted Therapy
100%
Neoplasm
33%
Androgen
33%
Chemotherapy
33%
Local Therapy
33%
Abiraterone
33%
Enzalutamide
33%
Cabazitaxel
33%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Prostate Cancer
100%
Neoplasm
33%
Androgen
33%
Abiraterone
33%
Cabazitaxel
33%
Enzalutamide
33%
Veterinary Science and Veterinary Medicine
Prostate Cancer
100%
Androgen
33%
Abiraterone
33%
Enzalutamide
33%